Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01194479 · ClinicalTrials.gov registry record · NA
Effect of Formoterol on the Counterregulatory Hormonal Response to Hypoglycemia in Type 1 Diabetes.
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT01194479 is a NA study that has completed, run by Yale University. The registered enrollment target is 14 participants.
The verdict
NCT01194479, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
Insulin treatment often causes the blood glucose levels to fall too low. The body usually responds to low blood glucose levels by releasing hormones which act against the insulin to help correct the low blood glucose levels. However, this hormone response can be altered in people with diabetes. Currently there are no therapeutic agents that can be used to improve the recovery from hypoglycemia (low blood sugar). The aim of this study is to determine whether a formoterol inhaler can be used to improve and accelerate the recovery from hypoglycemia in patients with type 1 diabetes.
Interventions
- OTHER Placebo
- DRUG Formoterol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2010-08 |
| Est. Completion | 2014-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01194479
The ClinicalTrials.gov registry entry for NCT01194479 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01194479 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01194479 about?
NCT01194479 is a clinical study titled "Effect of Formoterol on the Counterregulatory Hormonal Response to Hypoglycemia in Type 1 Diabetes.". Insulin treatment often causes the blood glucose levels to fall too low. The body usually responds to low blood glucose levels by releasing hormones which act against the insulin to help correct the low blood glucose levels. However, this hormone response can be altered in people with diabetes. Curr...
What is the current status of trial NCT01194479?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2010-08. Estimated completion is 2014-08.
What interventions are being tested in trial NCT01194479?
The interventions under investigation include: Placebo (OTHER), Formoterol (DRUG).
Who is sponsoring clinical trial NCT01194479?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.